These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23914752)

  • 1. A systematic review of the efficacy and safety of desipramine for treating ADHD.
    Ghanizadeh A
    Curr Drug Saf; 2013 Jul; 8(3):169-74. PubMed ID: 23914752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Himpel S; Banaschewski T; Heise CA; Rothenberger A
    Expert Opin Drug Saf; 2005 Mar; 4(2):311-21. PubMed ID: 15794722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children.
    Werry JS; Biederman J; Thisted R; Greenhill L; Ryan N
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1239-45; discussion 1245-8. PubMed ID: 7559320
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of magnesium therapy for treating attention deficit hyperactivity disorder.
    Ghanizadeh A
    Arch Iran Med; 2013 Jul; 16(7):412-7. PubMed ID: 23808779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J; Greenfield B
    Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR; Biederman J; Jellinek MS
    Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder.
    Ghanizadeh A
    Nord J Psychiatry; 2015 May; 69(4):241-8. PubMed ID: 25415763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of clinical trials of aripiprazole for treating attention deficit hyperactivity disorder.
    Ghanizadeh A
    Neurosciences (Riyadh); 2013 Oct; 18(4):323-9. PubMed ID: 24141455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine for treating ADHD symptoms in autism: a systematic review.
    Ghanizadeh A
    J Atten Disord; 2013 Nov; 17(8):635-40. PubMed ID: 22544388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
    Gualtieri CT; Keenan PA; Chandler M
    J Clin Psychopharmacol; 1991 Jun; 11(3):155-9. PubMed ID: 2066453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of adult ADHD and comorbid depression.
    Spencer TJ
    CNS Spectr; 2008 May; 13(5 Suppl 8):14-6. PubMed ID: 18567134
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.
    Maneeton B; Maneeton N; Likhitsathian S; Suttajit S; Narkpongphun A; Srisurapanont M; Woottiluk P
    Drug Des Devel Ther; 2015; 9():1927-36. PubMed ID: 25897203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD treatment across the life cycle.
    Spencer TJ
    J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.